| Neuraxpharm Switzerland AG - Desveneurax 100 mg, Retardtabletten | | 69469 | | 02 | | Desveneurax 100 mg | | Retardtabletten | | N06AX23 | | Desvenlafaxine | | 22.11.2024 | | |
| | Composition | | Tablette: desvenlafaxinum 100 mg ut desvenlafaxini benzoas, hypromellosum, cellulosum microcristallinum, talcum, acidum stearicum, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), E 110 0.145 mg, pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | Active Agent | Dose | additional_information |
|---|
| Desvenlafaxinum | 100 mg | Tablette |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Acidum Stearicum | | | | Cellulosum Microcristallinum | | | | E 110 | 0.145 mg | color. | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| |
|
